HUP0401613A3 - A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea - Google Patents

A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea

Info

Publication number
HUP0401613A3
HUP0401613A3 HU0401613A HUP0401613A HUP0401613A3 HU P0401613 A3 HUP0401613 A3 HU P0401613A3 HU 0401613 A HU0401613 A HU 0401613A HU P0401613 A HUP0401613 A HU P0401613A HU P0401613 A3 HUP0401613 A3 HU P0401613A3
Authority
HU
Hungary
Prior art keywords
ethoxy
phenyl
propanoic acid
sulonylurea
tert
Prior art date
Application number
HU0401613A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0401613A2 publication Critical patent/HUP0401613A2/hu
Publication of HUP0401613A3 publication Critical patent/HUP0401613A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0401613A 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea HUP0401613A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101982A SE0101982D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001036 WO2002100413A1 (en) 2001-06-01 2002-05-30 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA

Publications (2)

Publication Number Publication Date
HUP0401613A2 HUP0401613A2 (hu) 2004-11-29
HUP0401613A3 true HUP0401613A3 (en) 2007-11-28

Family

ID=20284364

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401613A HUP0401613A3 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea

Country Status (21)

Country Link
US (1) US20040157927A1 (hu)
EP (1) EP1399166A1 (hu)
JP (1) JP2004532891A (hu)
KR (1) KR20040007624A (hu)
CN (1) CN1250226C (hu)
BR (1) BR0210127A (hu)
CA (1) CA2448763A1 (hu)
CO (1) CO5540382A2 (hu)
CZ (1) CZ20033235A3 (hu)
EE (1) EE200300583A (hu)
HU (1) HUP0401613A3 (hu)
IL (1) IL159035A0 (hu)
IS (1) IS7057A (hu)
MX (1) MXPA03011010A (hu)
NO (1) NO20035235D0 (hu)
PL (1) PL367890A1 (hu)
RU (1) RU2003136157A (hu)
SE (1) SE0101982D0 (hu)
SK (1) SK14722003A3 (hu)
WO (1) WO2002100413A1 (hu)
ZA (1) ZA200309263B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ppar調節剤およびそのスクリーニング方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
CN1250226C (zh) 2006-04-12
CN1537008A (zh) 2004-10-13
CO5540382A2 (es) 2005-07-29
ZA200309263B (en) 2005-03-11
EE200300583A (et) 2004-02-16
EP1399166A1 (en) 2004-03-24
SE0101982D0 (sv) 2001-06-01
IL159035A0 (en) 2004-05-12
NO20035235D0 (no) 2003-11-25
HUP0401613A2 (hu) 2004-11-29
IS7057A (is) 2003-11-28
SK14722003A3 (sk) 2004-08-03
BR0210127A (pt) 2004-06-08
CZ20033235A3 (cs) 2004-12-15
PL367890A1 (en) 2005-03-07
KR20040007624A (ko) 2004-01-24
RU2003136157A (ru) 2005-05-20
MXPA03011010A (es) 2004-02-27
WO2002100413A1 (en) 2002-12-19
CA2448763A1 (en) 2002-12-19
US20040157927A1 (en) 2004-08-12
JP2004532891A (ja) 2004-10-28

Similar Documents

Publication Publication Date Title
NO20022591D0 (no) Finmalt form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}etoksy)fenyl]propansyre
DK1237855T3 (da) Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre
DE69841531D1 (de) Kennzeichnung von programminformation eines aufzeichnungsmediums
HUP0401613A3 (en) A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea
IL159034A0 (en) A pharmaceutical combination comprising either (s) -2-ethoxy-3-[4- (2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}- (s) -2- ethoxy propanoic acid and insulin
PL377735A1 (pl) Pochodne kwasu 4-(3-(2-fenylooksazol-4-ilometoksy)- cykloheksyloksy)- propano-1-karboksylowego i związki pokrewne, jako modulatory PPAR do leczenia cukrzycy typu 2 i stwardnienia naczyń
HUP0400946A3 (en) A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug
FR2838218B1 (fr) Affichage des imagettes d'un support photographique sur un terminal
DK1055658T3 (da) Fremstilling af cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphtalen-1-yl)phenoxy]ethyl-pyrrolidin
FR2811084B1 (fr) Methode d'identification d'une caracteristique biologique fonctionnelle d'une matiere vivante
NO20000665L (no) 2-{3-[4-(2-t-Butyl-6-trifluormetyl-4-pyrimidinyl)-1- piperazinyl]propyltio}-4-pyrimidinol-fumarat
DE60203142D1 (de) Verfahren zur Herstellung von 4-[1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-butyl]-alpha, alpha-dimethylphenylessigsäure
DE60001751T2 (de) Behälter zur Aufnahme eines Stapels ineinandergefalteter feuchter Tücher
FR2833171B1 (fr) Produit cosmetique/dermatologique a base d'emulsion triple
FR2809716B1 (fr) Chevalet destine a la manutention et au magasinage d'ensembles de plaques
JP3024219U (ja) コンパクトディスク用収納ケース
PT1147102E (pt) Inibidores de tace a base de acidos hidroxamicos de sulfonamidas e amidas de acido fosfinico heteroaril-acetilenicas
IT1306004B1 (it) Processo per l'ottenimento di materiali polimerici semicristallininanoporosi a base di polistirene sindiotattico in forma completamente
ITFI990072A0 (it) Processo per la produzione di carta tissue e carta cosi'ottenuta
FR2837832B1 (fr) Adjuvant de detergence a base d'ammonium quaternaire et d'un produit mouillant
PL3637S2 (pl) Pojemnik
NO20020213D0 (no) Svovelsyre mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin- 4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester
IT1299789B1 (it) Procedimento per ottenere un materiale plasmabile a base cartacea e materiale cosi' ottenuto
TH55077EX (th) รองเท้า

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees